PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 19 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
Silver nanoparticles synthesized using a polar extract of Aconitum lycoctonum L. demonstrated antioxidant potential (via FRAP and DPPH assays), inhibited the growth of Gram-positive and negative bacteria, and acted as amylase inhibitors [PMID:37770921]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35140011 (2022) — Poisoning by Plants. · Deutsches Arzteblatt international
- 2.PMID: 26227030 (2014) — Tetrodotoxin-Medicated Delay in Aconitine Toxicity: A Murder in Okinawa. · Forensic science review
- 3.PMID: 37770921 (2023) — Aconitum lycoctonum L. (Ranunculaceae) mediated biogenic synthesis of silver nanoparticles as potential antioxidant, anti-inflammatory, antimicrobial and antidiabetic agents. · BMC chemistry
- 4.PMID: 10346976 (1999) — Isolation of norditerpenoid alkaloids from flowers of aconitum lycoctonum. · Journal of natural products
- 5.PMID: 25772682 (2015) — Comparative floral spur anatomy and nectar secretion in four representatives of Ranunculaceae.